Company Overview - Jiangsu Xinhang New Materials Co., Ltd. is located in Nanjing, Jiangsu Province, and was established on July 25, 2008. The company went public on October 11, 2021. Its main business involves the research, production, and sales of aromatic ketone products [2] - The revenue composition of the company includes: 42.36% from specialty engineering plastics core materials, 20.64% from cosmetic raw materials, 20.25% from agricultural and pharmaceutical intermediates, and 16.75% from photoinitiators [2] Stock Performance - As of September 19, the stock price of Xinhang New Materials decreased by 2.02%, trading at 55.87 CNY per share, with a total market capitalization of 9.77 billion CNY [1] - Year-to-date, the stock price has increased by 135.66%, but it has seen a decline of 5.55% over the last five trading days. Over the last 20 days, the stock rose by 3.79%, and over the last 60 days, it surged by 111.20% [2] Financial Performance - For the first half of 2025, Xinhang New Materials reported a revenue of 229 million CNY, representing a year-on-year growth of 9.66%. The net profit attributable to shareholders was 35.29 million CNY, reflecting a year-on-year increase of 20.40% [3] - The company has distributed a total of 136 million CNY in dividends since its A-share listing, with 95.72 million CNY distributed over the past three years [4] Shareholder Information - As of September 10, the number of shareholders for Xinhang New Materials was 36,300, a decrease of 5.47% from the previous period. The average number of circulating shares per shareholder increased by 5.79% to 3,025 shares [3] - As of June 30, 2025, the sixth largest circulating shareholder is Penghua Carbon Neutral Theme Mixed A, holding 1.63 million shares as a new shareholder [4]

Company Overview - Xin Kai Yuan Medical Technology Group Co., Ltd. is located in Jiaozuo City, Henan Province, established on March 13, 2003, and listed on August 25, 2010. The company specializes in the R&D, production, and sales of PVP series products, PVME/MA high-value pharmaceutical excipients, and functional high polymer materials, as well as in vitro diagnostic services including early cancer diagnosis, molecular diagnostics, and gene sequencing [1][2]. Financial Performance - As of September 10, 2023, Xin Kai Yuan reported a revenue of 644 million yuan for the first half of 2025, a year-on-year decrease of 12.36%. The net profit attributable to the parent company was 139 million yuan, down 34.74% year-on-year [2]. - The company has cumulatively distributed 900 million yuan in dividends since its A-share listing, with 607 million yuan distributed over the past three years [3]. Stock Performance - On September 19, 2023, Xin Kai Yuan's stock price increased by 2.10%, reaching 17.49 yuan per share, with a trading volume of 155 million yuan and a turnover rate of 2.02%. The total market capitalization stood at 8.501 billion yuan [1]. - Year-to-date, the stock price has risen by 11.39%, but it has seen a decline of 2.45% over the last five trading days and 5.05% over the last 20 days, while increasing by 8.16% over the last 60 days [1]. Shareholder Information - As of September 10, 2023, the number of shareholders for Xin Kai Yuan was 20,500, a decrease of 6.39% from the previous period. The average number of circulating shares per person increased by 6.83% to 21,942 shares [2]. Business Segments - The main revenue sources for Xin Kai Yuan include: - PVP Others: 39.57% - PVPK30 Powder: 28.35% - Oruisi Series: 14.80% - PVP-I: 6.85% - Precision Medical Services: 3.45% - Early Cancer Diagnosis: 3.08% - Gene Testing Technology: 3.04% - Molecular Diagnostic Services: 0.87% [1]. Industry Classification - Xin Kai Yuan is classified under the Shenwan industry category of Basic Chemicals - Chemical Products - Other Chemical Products, and is associated with concepts such as stem cells, biomedicine, innovative drugs, cancer treatment, and precision medicine [2].

Company Overview - Baichuan Co., Ltd. is located in Jiangyin City, Jiangsu Province, and was established on July 1, 2002. The company was listed on August 3, 2010. Its main business involves fine chemicals, new materials, and new energy [1] - The revenue composition of Baichuan Co., Ltd. is as follows: chemical products account for 75.51%, new materials account for 18.65%, and new energy accounts for 5.84% [1] Financial Performance - As of June 30, 2025, Baichuan Co., Ltd. achieved an operating income of 2.91 billion yuan, representing a year-on-year growth of 10.40%. However, the net profit attributable to shareholders decreased by 47.06% to 53.93 million yuan [2] - Since its A-share listing, Baichuan Co., Ltd. has distributed a total of 550 million yuan in dividends, with 65.31 million yuan distributed over the past three years [3] Stock Market Activity - On September 19, Baichuan Co., Ltd. saw its stock price increase by 2.10%, reaching 7.28 yuan per share, with a trading volume of 141 million yuan and a turnover rate of 3.78%. The total market capitalization is 4.326 billion yuan [1] - Year-to-date, the stock price has decreased by 1.75%, but it has increased by 4.90% over the last five trading days and by 3.41% over the last 20 days [1] - As of June 30, 2025, the number of shareholders is 80,600, a decrease of 6.93% from the previous period, while the average number of circulating shares per person increased by 7.44% to 6,438 shares [2] Shareholding Structure - As of June 30, 2025, Hong Kong Central Clearing Limited is the fifth-largest circulating shareholder, holding 2.8441 million shares, an increase of 859,400 shares compared to the previous period [3]

Core Viewpoint - Lingpai Technology's stock price has shown significant volatility, with a year-to-date increase of 113.17% but a recent decline of 6.96% over the past five trading days [2] Company Overview - Lingpai Technology, established on December 12, 2002, and listed on August 9, 2016, is located in Qidong County, Hunan Province. The company specializes in the research, production, and sales of new environmentally friendly surface engineering chemicals and new energy power battery businesses [2] - The company's revenue composition includes: 33.11% from new energy EPC business, 33.11% from new energy batteries and systems, 29.04% from coating additives, 3.81% from other sources, 0.77% from coating intermediates, and 0.16% from chemical trading products [2] Financial Performance - As of September 10, 2023, Lingpai Technology reported a revenue of 67.48 million yuan for the first half of 2025, a year-on-year decrease of 1.19%. The net profit attributable to the parent company was -70.57 million yuan, reflecting a year-on-year increase of 20.56% [3] - The company has distributed a total of 296 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [4] Shareholder Information - As of September 10, 2023, the number of shareholders increased by 10.53% to 25,200, with an average of 6,282 circulating shares per person, a decrease of 9.52% [3] - As of June 30, 2025, the top ten circulating shareholders included new entrants such as China Aviation New Start Flexible Allocation Mixed A, holding 895,800 shares, and a decrease in holdings by China National Offshore Oil Corporation Energy Strategy Mixed [4]

Core Viewpoint - The stock of Huan Yuan Gas has experienced fluctuations, with a year-to-date increase of 67.12%, but a recent decline of 2.21% on September 18, 2023, indicating potential volatility in the market [1]. Company Overview - Huan Yuan Gas, established on November 20, 2003, and listed on January 13, 2020, is located in Yichang, Hubei Province. The company specializes in the research, production, sales, and service of various gas products, as well as the recycling of industrial waste gas [1]. - The company's revenue composition includes bulk gases (49.40%), industrial chemicals (30.51%), clean energy (12.30%), other projects (3.79%), electronic specialty gases and chemicals (3.32%), and waste gas recovery (0.68%) [1]. Financial Performance - For the first half of 2025, Huan Yuan Gas reported a revenue of 806 million yuan, reflecting a year-on-year growth of 4.36%. The net profit attributable to shareholders was 49.17 million yuan, showing a year-on-year increase of 12.43% [2]. - Since its A-share listing, the company has distributed a total of 106 million yuan in dividends, with 58.25 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2023, the number of shareholders for Huan Yuan Gas was 9,022, a decrease of 7.87% from the previous period. The average circulating shares per person increased by 8.55% to 17,845 shares [2]. - As of June 30, 2025, among the top ten circulating shareholders, Huaxia Industry Prosperity Mixed Fund (003567) ranked as the eighth largest, holding 4.80 million shares, an increase of 1.14 million shares compared to the previous period [3].

Company Overview - Sinochem International is located in the China (Shanghai) Free Trade Zone and was established on December 14, 1998, with its listing date on March 1, 2000. The company specializes in fine chemical businesses, including chemical new materials and agricultural chemicals [2] - The revenue composition of Sinochem International includes: Other 31.04%, Chemical Material Marketing 29.68%, High-Performance Materials 17.53%, Basic Raw Materials and Intermediates 14.48%, and Polymer Additives 7.28% [2] - As of June 30, the number of shareholders of Sinochem International was 70,600, an increase of 1.76% from the previous period, with an average of 50,797 circulating shares per person, a decrease of 1.73% [2] Financial Performance - For the first half of 2025, Sinochem International achieved operating revenue of 24.353 billion yuan, a year-on-year decrease of 5.83%. The net profit attributable to the parent company was -886 million yuan, a year-on-year decrease of 7.29194 billion yuan [2] - The company has cumulatively distributed 5.533 billion yuan in dividends since its A-share listing, with 539 million yuan distributed in the last three years [3] Stock Performance - On September 18, Sinochem International's stock price fell by 2.02%, trading at 4.37 yuan per share, with a total market capitalization of 15.682 billion yuan [1] - Year-to-date, the stock price has increased by 8.71%, with a decline of 4.17% over the last five trading days, a rise of 3.80% over the last 20 days, and an increase of 17.79% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on July 29, where it recorded a net purchase of 546.943 million yuan [1]

Group 1 - Dagan Holdings' shareholder plans to reduce holdings by up to 3% of the company's shares, totaling approximately 9.52 million shares [1] - China Resources Sanjiu intends to invest up to 10 billion yuan of its own funds in bank wealth management products, with a rolling investment strategy [1] - Xinyu Guoke's shareholder plans to reduce holdings by up to 1% of the company's shares, totaling approximately 276.76 thousand shares [3] Group 2 - Tianpu Co. has completed the stock trading suspension review and will resume trading after a period of abnormal price fluctuations [5] - Xinhang New Materials' controlling shareholder plans to reduce holdings by up to 2% of the company's shares, totaling approximately 174.88 thousand shares [6] - Yinbang Co.'s shareholder plans to reduce holdings by up to 3% of the company's shares, totaling approximately 24.66 million shares [7] Group 3 - Yuanfei Pet's shareholders plan to collectively reduce holdings by up to 3.48% of the company's shares, totaling approximately 565.14 thousand shares [7] - Changchun High-tech's subsidiary will gain exclusive agency rights for three products in mainland China [9] - Hanyi Co.'s controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling approximately 294 thousand shares [10] Group 4 - Zhongcai Energy's subsidiary signed a total contract worth 347 million yuan for a project in Hubei Province [11] - Ruifeng Bank's shareholder reduced holdings by 408.83 thousand shares, decreasing their ownership from 6.10% to 5.89% [12] - Shanghai Construction's gold business revenue is low, accounting for less than 0.5% of total revenue [13] Group 5 - Guanggang Gas's shareholder plans to reduce holdings by up to 2.63 million shares, approximately 1.9994% of the company's total shares [14] - Kairun Co.'s controlling shareholder has decided to terminate the share reduction plan early [15] - Boyun New Materials' shareholder plans to reduce holdings by up to 1% of the company's shares, totaling approximately 573 thousand shares [16] Group 6 - Yuanda Environmental's acquisition of assets and fundraising has been approved by the Shanghai Stock Exchange [17] - ST Ningke's stock will be subject to delisting risk warning due to the company's restructuring [18] - Anke Biotech's investee company has received approval for a key II phase clinical trial for a new injection [19] Group 7 - Shuanglu Pharmaceutical's director plans to reduce holdings by up to 37.52 thousand shares, approximately 0.0365% of the company's total shares [20] - Zhongji Xuchuang's specific shareholder's holding ratio changed by more than 1% [21] - ST Nanzhi plans to sell real estate development and leasing business assets for 1 yuan to focus on urban operation [22]

Company Overview - Baichuan Co., Ltd. is located in Jiangyin City, Jiangsu Province, and was established on July 1, 2002. The company was listed on August 3, 2010. Its main business involves fine chemicals, new materials, and new energy sectors [1]. - The revenue composition of Baichuan Co., Ltd. is as follows: chemical products account for 75.51%, new materials account for 18.65%, and new energy accounts for 5.84% [1]. Financial Performance - As of June 30, 2025, Baichuan Co., Ltd. achieved an operating income of 2.91 billion yuan, representing a year-on-year growth of 10.40%. However, the net profit attributable to shareholders decreased by 47.06% to 53.93 million yuan [2]. - Since its A-share listing, Baichuan Co., Ltd. has distributed a total of 550 million yuan in dividends, with 65.31 million yuan distributed over the past three years [3]. Stock Market Activity - On September 18, Baichuan Co., Ltd.'s stock price increased by 2.26%, reaching 7.25 yuan per share, with a trading volume of 190 million yuan and a turnover rate of 5.17%. The total market capitalization is 4.308 billion yuan [1]. - Year-to-date, the stock price has decreased by 2.16%, but it has increased by 3.13% over the last five trading days, 2.40% over the last 20 days, and 0.14% over the last 60 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders of Baichuan Co., Ltd. is 80,600, a decrease of 6.93% from the previous period. The average number of circulating shares per person is 6,438, an increase of 7.44% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fifth largest, holding 2.8441 million shares, an increase of 859,400 shares compared to the previous period [3]. Capital Flow - In terms of capital flow, there was a net outflow of 7.27 million yuan from main funds, with large orders buying 29.55 million yuan (15.54% of total) and selling 38.30 million yuan (20.14% of total) [1].

Group 1 - Dashi Intelligent signed a contract worth 23.86 million yuan for the Xiaomi Wuhan Phase II smart project, providing a comprehensive smart space solution [1] - ST Tian Sheng's subsidiary passed the consistency evaluation for sodium bicarbonate injection, used for treating metabolic acidosis and certain drug poisonings [1] - Yongyue Technology's actual controller Chen Xiang was released on bail due to allegations of information disclosure violations, while the company's operations remain normal [2] Group 2 - Jushen Co. experienced a stock price fluctuation with a cumulative increase of over 20% over three trading days, while also planning to reduce repurchased shares [2][3] - Shanghai Airport reported a 6.9% year-on-year increase in passenger throughput at Pudong International Airport, totaling 7.9471 million passengers in August [3][4] - Jianlong Micro-Nano announced plans for shareholders to reduce up to 3% of company shares due to fund expiration and exit arrangements [5][6] Group 3 - Yunyong Technology's shareholders plan to reduce up to 2.99% of company shares due to personal funding needs [6] - Zitian Tui's stock entered a delisting arrangement period, expected to last 15 trading days [7] - Pruis's shareholders plan to reduce up to 3% of company shares for personal funding needs [9] Group 4 - Dayilong's shareholders plan to reduce up to 3% of company shares for personal financial arrangements [10] - Yihua New Materials' shareholders plan to reduce up to 1% of company shares for personal funding needs [12] - Huibo Yuntong's controlling shareholder's affiliates plan to acquire a controlling stake in Baode Computer [13] Group 5 - Wanda Information's shareholders plan to reduce up to 3% of company shares for operational needs [14] - Jiafa Education's shareholders plan to reduce up to 3% of company shares for personal funding needs [15] - Guangkang Biochemical's shareholders plan to reduce up to 1.8% of company shares for personal funding needs [16] Group 6 - Yingxin Development's shareholders plan to reduce up to 0.67% of company shares due to bankruptcy asset disposal [18] - Weiye Co.'s shareholders plan to reduce a total of up to 2% of company shares [19] - Kelin Electric plans to raise up to 1.5 billion yuan through a private placement to supplement working capital [20]

Core Viewpoint - The stock of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has shown significant price increases this year, with a year-to-date rise of 108.17% as of September 15, 2023, despite a recent decline in trading [1][2]. Group 1: Company Overview - Shandong Boyuan Pharmaceutical Chemical Co., Ltd. was established on August 6, 2008, and is located in Shouguang City, Shandong Province [2]. - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2]. - The revenue composition of the company includes 74.56% from iodides, 12.79% from specialty functional chemicals, 9.94% from trading, and 2.72% from other sources [2]. Group 2: Financial Performance - For the first half of 2025, the company achieved operating revenue of 747 million yuan, representing a year-on-year growth of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.04 million yuan [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. Group 3: Stock Performance and Trading Activity - As of September 15, 2023, the stock price was 80.64 yuan per share, with a market capitalization of 10.777 billion yuan [1]. - The stock has experienced a trading volume of 1.17 billion yuan, with a turnover rate of 4.25% [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent net buy of 51.18 million yuan on September 9, 2023 [1].